Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT04230109 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 260 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | October 14, 2025 (Oct 14, 2025) |
As of March 2, 2026: Clinical trial NCT04230109 is currently recruiting participants. This clinical trial study for triple negative breast cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04230109 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04230109 was last updated Oct 14, 2025 (October 14, 2025). HelloStudys verifies this status automatically.